ProCE Banner Activity


A Balancing Act: Strategies for Safe and Effective T2D Management in Older Adults

PCE On Demand Live Presentation

Individualization of glycemic targets and choice of medication is key when caring for older adults with type 2 diabetes (T2D). When choosing pharmacologic therapy for these patients, patient-specific factors should be considered such as A1C, duration of diabetes, weight, age, comorbidities, hypoglycemia risk, cost of medication, complexity of regimen, and patient preference. In this 1-hour webcast, 2 experts in diabetes management review guideline recommendations for individualizing care for older adults with T2D, as well as discuss the role of fixed ratio combinations (FRCs) to improve adherence. 

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: November 03, 2022

Expiration: November 02, 2023

No longer available for credit.



Lucia M Novak

Lucia M Novak, MSN, ANP-BC, BC-ADM

President, Diabesity, LLC
North Bethesda, Maryland
Co-Executive Director, Capital Health and Metabolic Center
Capital Diabetes and Endocrine Associates
Camp Springs and Silver Spring, Maryland

Richard E. Pratley

Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research
Medical Director
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Orlando, Florida

Provided by

ProCE Banner


This activity is supported by an educational grant from

Sanofi US



ProCE Banner

Target Audience

NPs and PAs that practice in endocrinology

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify glycemic goals and therapies that minimize adverse events and improve outcomes in older adults with T2D

  • Apply clinical evidence for FRCs into the management of older adults with T2D according to guideline recommendations and patient factors

  • Modify a T2D treatment and monitoring plan for an older adult in an LTCF with considerations for regimen complexity and adverse events


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Richard E. Pratley, MD: researcher: Hanmi Pharmaceuticals, Metavention, Novo Nordisk, Poxel SA, Sanofi; consultant/advisor/speaker: Bayer, Corcept Therapeutics, Dexcom, Gasherbrum Bio, Hanmi Pharmaceuticals, Hengrui USA, Merck, Metavention, Novo Nordisk, Pfizer, Poxel SA, Rivus Pharmaceuticals, Sanofi, Scohia Pharma, Sun Pharmaceuticals

Lucia M. Novak, MSN, ANP-BC, BC-ADM: consultant/advisor/speaker: Abbott Diabetes Care, Boehringer Ingelheim/Lilly, Novo Nordisk, Provention Bio, Xeris

None of the members of the Planning Committee, PACE, PCE, or GAPNA staff have any relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form

The estimated time to complete this activity is 1.00 hour.

Release date: November 3, 2022
Expiration date: November 2, 2023


This program has been made available online.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, Gerontological Advanced Practice Nurses Association, or any educational supporter.


Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation

Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit


AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until November 2, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Dave Faldmo, PA-C, MPAS, CHCEF, Siouxland Community Health Center, Sioux City, Iowa


IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.

Additional Information

Program Medium

This program has been made available online.